Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 252

1.

Correction to: Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.

Ruscica M, Pavanello C, Gandini S, Macchi C, Botta M, Dall'Orto D, Del Puppo M, Bertolotti M, Bosisio R, Mombelli G, Sirtori CR, Calabresi L, Magni P.

Nutr J. 2019 Sep 9;18(1):54. doi: 10.1186/s12937-019-0483-x.

2.

Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159).

Marvaso G, Ciardo D, Corrao G, Gandini S, Fodor C, Zerini D, Rojas DP, Augugliaro M, Bonizzi G, Pece S, Cattani F, Mazzocco K, Mistretta FA, Musi G, Alessi S, Petralia G, Pravettoni G, De Cobelli O, Di Fiore PP, Viale G, Orecchia R, Jereczek-Fossa BA.

BMC Cancer. 2019 Sep 10;19(1):903. doi: 10.1186/s12885-019-6117-z.

3.

Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy.

Passaro A, Mancuso P, Gandini S, Spitaleri G, Labanca V, Guerini-Rocco E, Barberis M, Catania C, Del Signore E, de Marinis F, Bertolini F.

Clin Transl Oncol. 2019 Aug 20. doi: 10.1007/s12094-019-02198-5. [Epub ahead of print]

PMID:
31432394
4.

Comparison of Outcomes and Toxicity Between Extreme and Moderate Radiation Therapy Hypofractionation in Localized Prostate Cancer: A Propensity Score Analysis.

Marvaso G, Ciardo D, Gandini S, Riva G, Frigo E, Volpe S, Fodor C, Zerini D, Rojas DP, Comi S, Cambria R, Cattani F, Musi G, De Cobelli O, Orecchia R, Jereczek-Fossa BA.

Int J Radiat Oncol Biol Phys. 2019 Aug 1. pii: S0360-3016(19)33531-X. doi: 10.1016/j.ijrobp.2019.07.027. [Epub ahead of print]

PMID:
31377161
5.

Tumor mutational burden quantification from targeted gene panels: major advancements and challenges.

Fancello L, Gandini S, Pelicci PG, Mazzarella L.

J Immunother Cancer. 2019 Jul 15;7(1):183. doi: 10.1186/s40425-019-0647-4. Review.

6.

Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy.

Passaro A, Mancuso P, Gandini S, Spitaleri G, Labanca V, Guerini-Rocco E, Barberis M, Catania C, Del Signore E, de Marinis F, Bertolini F.

Clin Transl Oncol. 2019 Jun 28. doi: 10.1007/s12094-019-02166-z. [Epub ahead of print] Erratum in: Clin Transl Oncol. 2019 Aug 20;:.

PMID:
31254252
7.

Development and validation of the Family Resilience (FaRE) Questionnaire: an observational study in Italy.

Faccio F, Gandini S, Renzi C, Fioretti C, Crico C, Pravettoni G.

BMJ Open. 2019 Jun 5;9(6):e024670. doi: 10.1136/bmjopen-2018-024670. Erratum in: BMJ Open. 2019 Sep 4;9(9):e024670corr1.

8.

Stereotactic radiation therapy in oligometastatic colorectal cancer: outcome of 102 patients and 150 lesions.

Dell'Acqua V, Surgo A, Kraja F, Kobiela J, Zerella MA, Spychalski P, Gandini S, Francia CM, Ciardo D, Fodor C, Ferrari AM, Piperno G, Cattani F, Vigorito S, Pansini F, Petz W, Orecchia R, Leonardi MC, Jereczek-Fossa BA.

Clin Exp Metastasis. 2019 Aug;36(4):331-342. doi: 10.1007/s10585-019-09976-z. Epub 2019 Jun 4.

PMID:
31165360
9.

Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective.

Ombra MN, Paliogiannis P, Stucci LS, Colombino M, Casula M, Sini MC, Manca A, Palomba G, Stanganelli I, Mandalà M, Gandini S, Lissia A, Doneddu V, Cossu A, Palmieri G; Italian Melanoma Intergroup (IMI).

Nutr Metab (Lond). 2019 May 21;16:33. doi: 10.1186/s12986-019-0365-4. eCollection 2019. Review.

10.

Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer.

Johansson H, Aristarco V, Gandini S, Gjerde J, Macis D, Guerrieri-Gonzaga A, Serrano D, Lazzeroni M, Rajasekaran A, Williard CV, Mellgren G, DeCensi A, Bonanni B.

Pharmacogenomics J. 2019 Apr 10. doi: 10.1038/s41397-019-0087-z. [Epub ahead of print]

PMID:
30967597
11.

The role of the T-N tract in advanced stage tongue cancer.

Tagliabue M, Gandini S, Maffini F, Navach V, Bruschini R, Giugliano G, Lombardi F, Chiocca S, Rebecchi E, Sica E, Tommasino M, Calabrese L, Ansarin M.

Head Neck. 2019 Aug;41(8):2756-2767. doi: 10.1002/hed.25761. Epub 2019 Apr 3.

PMID:
30942940
12.

Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation.

Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, Beghini F, Manara S, Karcher N, Pozzi C, Gandini S, Serrano D, Tarallo S, Francavilla A, Gallo G, Trompetto M, Ferrero G, Mizutani S, Shiroma H, Shiba S, Shibata T, Yachida S, Yamada T, Wirbel J, Schrotz-King P, Ulrich CM, Brenner H, Arumugam M, Bork P, Zeller G, Cordero F, Dias-Neto E, Setubal JC, Tett A, Pardini B, Rescigno M, Waldron L, Naccarati A, Segata N.

Nat Med. 2019 Apr;25(4):667-678. doi: 10.1038/s41591-019-0405-7. Epub 2019 Apr 1.

PMID:
30936548
13.

Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer.

Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, Fleck JS, Voigt AY, Palleja A, Ponnudurai R, Sunagawa S, Coelho LP, Schrotz-King P, Vogtmann E, Habermann N, Niméus E, Thomas AM, Manghi P, Gandini S, Serrano D, Mizutani S, Shiroma H, Shiba S, Shibata T, Yachida S, Yamada T, Waldron L, Naccarati A, Segata N, Sinha R, Ulrich CM, Brenner H, Arumugam M, Bork P, Zeller G.

Nat Med. 2019 Apr;25(4):679-689. doi: 10.1038/s41591-019-0406-6. Epub 2019 Apr 1.

PMID:
30936547
14.

Identifying Drug Repurposing Opportunities in Oncology.

Orecchioni S, Roma S, Raimondi S, Gandini S, Bertolini F.

Cancer J. 2019 Mar/Apr;25(2):82-87. doi: 10.1097/PPO.0000000000000360.

PMID:
30896529
15.

MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.

Pellegrini C, Botta F, Massi D, Martorelli C, Facchetti F, Gandini S, Maisonneuve P, Avril MF, Demenais F, Bressac-de Paillerets B, Hoiom V, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Marrett L, Zanetti R, Dwyer T, Thomas NE, Begg CB, Berwick M, Puig S, Potrony M, Nagore E, Ghiorzo P, Menin C, Manganoni AM, Rodolfo M, Brugnara S, Passoni E, Sekulovic LK, Baldini F, Guida G, Stratigos A, Ozdemir F, Ayala F, Fernandez-de-Misa R, Quaglino P, Ribas G, Romanini A, Migliano E, Stanganelli I, Kanetsky PA, Pizzichetta MA, García-Borrón JC, Nan H, Landi MT, Little J, Newton-Bishop J, Sera F, Fargnoli MC, Raimondi S; IMI Study Group; GEM Study Group; M-SKIP Study Group.

Lancet Child Adolesc Health. 2019 May;3(5):332-342. doi: 10.1016/S2352-4642(19)30005-7. Epub 2019 Mar 12.

PMID:
30872112
16.

Vitamin D serum levels in children with vernal keratoconjunctivitis and disease control.

Ghiglioni DG, Bruschi G, Gandini S, Osnaghi S, Peroni D, Marchisio P.

Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419833468. doi: 10.1177/2058738419833468.

17.

Prevalence and determinants of sunbed use in thirty European countries: data from the Euromelanoma skin cancer prevention campaign.

Suppa M, Gandini S, Njimi H, Bulliard JL, Correia O, Duarte AF, Peris K, Stratigos AJ, Nagore E, Longo MI, Bylaite-Bucinskiene M, Karls R, Helppikangas H; Euromelanoma Working Group,, Del Marmol V.

J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:13-27. doi: 10.1111/jdv.15311.

PMID:
30811698
18.

Overview on vitamin D and sunbed use.

Pierret L, Suppa M, Gandini S, Del Marmol V, Gutermuth J.

J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:28-33. doi: 10.1111/jdv.15316. Review.

PMID:
30811696
19.

Epidemiological evidence of carcinogenicity of sunbed use and of efficacy of preventive measures.

Gandini S, Doré JF, Autier P, Greinert R, Boniol M.

J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:57-62. doi: 10.1111/jdv.15320. Review.

PMID:
30811691
20.

Who, why, where: an overview of determinants of sunbed use in Europe.

Suppa M, Gandini S, Bulliard JL, Daxhelet M, Zamagni M, Forsea AM, Longo MI, Del Marmol V.

J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:6-12. doi: 10.1111/jdv.15318. Review.

PMID:
30811690
21.

Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaign.

Suppa M, Gandini S, Njimi H, Bulliard JL, Correia O, Duarte AF, Peris K, Stratigos AJ, Nagore E, Longo MI, Bylaite-Bucinskiene M, Karls R, Helppikangas H; Euromelanoma Working Group,, Del Marmol V.

J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:76-88. doi: 10.1111/jdv.15307.

PMID:
30811689
22.

Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.

Ruscica M, Pavanello C, Gandini S, Macchi C, Botta M, Dall'Orto D, Del Puppo M, Bertolotti M, Bosisio R, Mombelli G, Sirtori CR, Calabresi L, Magni P.

Nutr J. 2019 Feb 22;18(1):13. doi: 10.1186/s12937-019-0438-2. Erratum in: Nutr J. 2019 Sep 9;18(1):54.

23.

The risk of extra-ovarian malignancies among women with endometriosis: A systematic literature review and meta-analysis.

Gandini S, Lazzeroni M, Peccatori FA, Bendinelli B, Saieva C, Palli D, Masala G, Caini S.

Crit Rev Oncol Hematol. 2019 Feb;134:72-81. doi: 10.1016/j.critrevonc.2018.12.009. Epub 2019 Jan 9.

PMID:
30771877
24.

Sunbeds and melanoma risk: time to close the debate.

Suppa M, Gandini S.

Curr Opin Oncol. 2019 Mar;31(2):65-71. doi: 10.1097/CCO.0000000000000507.

PMID:
30676536
25.

Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.

Jereczek-Fossa BA, Maucieri A, Marvaso G, Gandini S, Fodor C, Zerini D, Riva G, Alessandro O, Surgo A, Volpe S, Fanetti G, Arculeo S, Zerella MA, Parisi S, Maisonneuve P, Vavassori A, Cattani F, Cambria R, Garibaldi C, Starzyńska A, Musi G, De Cobelli O, Ferro M, Nolè F, Ciardo D, Orecchia R.

Med Oncol. 2018 Nov 27;36(1):9. doi: 10.1007/s12032-018-1233-1.

PMID:
30483899
26.

A meta-analysis of melanoma risk in industrial workers.

Vujic I, Gandini S, Stanganelli I, Fierro MT, Rappersberger K, Sibilia M, Tosti G, Ferrucci PF, Caini S, De Felici MB, Pagliarello C, Quaglino P, Sanlorenzo M; on behalf of IMI, the Italian Melanoma Intergroup.

Melanoma Res. 2018 Oct 26. doi: 10.1097/CMR.0000000000000531. [Epub ahead of print]

PMID:
30371537
27.

Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women.

Serrano D, Gandini S, Guerrieri-Gonzaga A, Feroce I, Johansson H, Macis D, Aristarco V, Bonanni B, DeCensi A.

Cancer Prev Res (Phila). 2018 Dec;11(12):811-818. doi: 10.1158/1940-6207.CAPR-18-0073. Epub 2018 Oct 23.

PMID:
30352838
28.

Left main coronary wall thickness correlates with the carotid intima media thickness and may provide a new marker of cardiovascular risk.

Ruscica M, Castelnuovo S, Macchi C, Gandini S, Mombelli G, Ferri N, Labombarda F, Sirtori CR.

Eur J Prev Cardiol. 2019 Jun;26(9):1001-1004. doi: 10.1177/2047487318806985. Epub 2018 Oct 22. No abstract available.

PMID:
30348004
29.

Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday.

Lazzari R, Ronchi S, Gandini S, Surgo A, Volpe S, Piperno G, Comi S, Pansini F, Fodor C, Orecchia R, Tomao F, Parma G, Colombo N, Jereczek-Fossa BA.

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):650-660. doi: 10.1016/j.ijrobp.2018.03.058. Epub 2018 Apr 4.

PMID:
29893277
30.

Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors.

Stucci LS, D'Oronzo S, Tucci M, Macerollo A, Ribero S, Spagnolo F, Marra E, Picasso V, Orgiano L, Marconcini R, De Rosa F, Di Guardo L, Galli G, Gandini S, Palmirotta R, Palmieri G, Queirolo P, Silvestris F; Italian Melanoma Intergroup (IMI).

Cancer Treat Rev. 2018 Sep;69:21-28. doi: 10.1016/j.ctrv.2018.05.016. Epub 2018 May 31. Review.

PMID:
29864718
31.

MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project.

Tagliabue E, Gandini S, Bellocco R, Maisonneuve P, Newton-Bishop J, Polsky D, Lazovich D, Kanetsky PA, Ghiorzo P, Gruis NA, Landi MT, Menin C, Fargnoli MC, García-Borrón JC, Han J, Little J, Sera F, Raimondi S.

Cancer Manag Res. 2018 May 14;10:1143-1154. doi: 10.2147/CMAR.S155283. eCollection 2018.

32.

"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach.

Marvaso G, Riva G, Ciardo D, Gandini S, Fodor C, Zerini D, Colangione SP, Timon G, Comi S, Cambria R, Cattani F, De Cobelli O, Orecchia R, Jereczek-Fossa BA.

Med Oncol. 2018 May 10;35(6):96. doi: 10.1007/s12032-018-1155-y.

PMID:
29748830
33.

Sun-Protection Behavior, Pubertal Development and Menarche: Factors Influencing the Melanocytic Nevi Development-The Results of an Observational Study of 1,512 Children.

De Giorgi V, Gori A, Greco A, Savarese I, Alfaioli B, Grazzini M, Rossari S, Papi F, Scarfi F, Janowska A, D'Errico A, Salvati L, Covarelli P, Gandini S.

J Invest Dermatol. 2018 Oct;138(10):2144-2151. doi: 10.1016/j.jid.2018.02.046. Epub 2018 Apr 1.

PMID:
29614272
34.

Fatherhood during dabrafenib and trametinib therapy for metastatic melanoma.

Cocorocchio E, Pala L, Battaglia A, Gandini S, Peccatori FA, Ferrucci PF.

Acta Oncol. 2018 Aug;57(8):1131-1133. doi: 10.1080/0284186X.2018.1449251. Epub 2018 Mar 11. No abstract available.

PMID:
29526130
35.

Axillary web syndrome assessment using a self-assessment questionnaire: a prospective cohort study.

Baggi F, Nevola Teixeira LF, Gandini S, Simoncini MC, Bonacossa E, Sandrin F, Sciotto Marotta M, Lanni G, Dadda P, Colpani D, Luini A.

Support Care Cancer. 2018 Aug;26(8):2801-2807. doi: 10.1007/s00520-018-4123-3. Epub 2018 Mar 5.

PMID:
29508139
36.

Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis.

Gandini S, Palli D, Spadola G, Bendinelli B, Cocorocchio E, Stanganelli I, Miligi L, Masala G, Caini S.

Crit Rev Oncol Hematol. 2018 Feb;122:1-9. doi: 10.1016/j.critrevonc.2017.12.003. Epub 2017 Dec 13. Review.

PMID:
29458778
37.

25-Hydroxyvitamin D serum levels and melanoma risk: a case-control study and evidence synthesis of clinical epidemiological studies.

Cattaruzza MS, Pisani D, Fidanza L, Gandini S, Marmo G, Narcisi A, Bartolazzi A, Carlesimo M.

Eur J Cancer Prev. 2019 May;28(3):203-211. doi: 10.1097/CEJ.0000000000000437.

PMID:
29438161
38.

Alcohol, alcoholic beverages, and melanoma risk: a systematic literature review and dose-response meta-analysis.

Gandini S, Masala G, Palli D, Cavicchi B, Saieva C, Ermini I, Baldini F, Gnagnarella P, Caini S.

Eur J Nutr. 2018 Oct;57(7):2323-2332. doi: 10.1007/s00394-018-1613-5. Epub 2018 Jan 11.

PMID:
29327230
39.

Memories of paternal relations are associated with coping and defense mechanisms in breast cancer patients: an observational study.

Renzi C, Perinel G, Arnaboldi P, Gandini S, Vadilonga V, Rotmensz N, Tagini A, Didier F, Pravettoni G.

BMC Psychol. 2017 Nov 9;5(1):37. doi: 10.1186/s40359-017-0206-z.

40.

Baseline relative eosinophil count as a predictive biomarker for ipilimumab treatment in advanced melanoma.

Ferrucci PF, Gandini S, Cocorocchio E, Pala L, Baldini F, Mosconi M, Antonini Cappellini GC, Albertazzi E, Martinoli C.

Oncotarget. 2017 Aug 1;8(45):79809-79815. doi: 10.18632/oncotarget.19748. eCollection 2017 Oct 3.

41.

Carcinogenicity of High Consumption of Meat and Lung Cancer Risk Among Non-Smokers: A Comprehensive Meta-Analysis.

Gnagnarella P, Caini S, Maisonneuve P, Gandini S.

Nutr Cancer. 2018 Jan;70(1):1-13. doi: 10.1080/01635581.2017.1374420. Epub 2017 Oct 10.

PMID:
29016198
42.

Propranolol for Off-label Treatment of Patients With Melanoma: Results From a Cohort Study.

De Giorgi V, Grazzini M, Benemei S, Marchionni N, Botteri E, Pennacchioli E, Geppetti P, Gandini S.

JAMA Oncol. 2018 Feb 8;4(2):e172908. doi: 10.1001/jamaoncol.2017.2908. Epub 2018 Feb 8.

43.

Clinical benefit and risk of death with endocrine therapy in ovarian cancer: A comprehensive review and meta-analysis.

Paleari L, Gandini S, Provinciali N, Puntoni M, Colombo N, DeCensi A.

Gynecol Oncol. 2017 Sep;146(3):504-513. doi: 10.1016/j.ygyno.2017.06.036. Epub 2017 Jul 10. Review.

44.

Erratum to: Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis.

Caini S, Cattaruzza MS, Bendinelli B, Tosti G, Masala G, Gnagnarella P, Assedi M, Stanganelli I, Palli D, Gandini S.

Eur J Nutr. 2017 Aug;56(5):2005. doi: 10.1007/s00394-017-1439-6. No abstract available.

PMID:
28488131
45.

Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.

Alterio D, Marvaso G, Maffini F, Gandini S, Chiocca S, Ferrari A, Preda L, Rocca MC, Lepanto D, Fodor C, Volpe S, Dicuonzo S, Laudati A, Giugliano G, Ansarin M, Jereczek-Fossa BA.

Med Oncol. 2017 Jun;34(6):107. doi: 10.1007/s12032-017-0965-7. Epub 2017 Apr 27.

PMID:
28452036
46.

A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer.

Lazzeroni M, Guerrieri-Gonzaga A, Gandini S, Johansson H, Serrano D, Cazzaniga M, Aristarco V, Macis D, Mora S, Caldarella P, Pagani G, Pruneri G, Riva A, Petrangolini G, Morazzoni P, DeCensi A, Bonanni B.

Cancer Prev Res (Phila). 2017 Jun;10(6):363-370. doi: 10.1158/1940-6207.CAPR-16-0298. Epub 2017 Apr 11.

47.

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.

Ferrucci PF, Ascierto PA, Pigozzo J, Del Vecchio M, Maio M, Antonini Cappellini GC, Guidoboni M, Queirolo P, Savoia P, Mandalà M, Simeone E, Valpione S, Altomonte M, Spagnolo F, Cocorocchio E, Gandini S, Giannarelli D, Martinoli C.

Ann Oncol. 2018 Feb 1;29(2):524. doi: 10.1093/annonc/mdx059. No abstract available.

PMID:
28379318
48.

β-Blocker use and reduced disease progression in patients with thick melanoma: 8 years of follow-up.

De Giorgi V, Grazzini M, Benemei S, Marchionni N, Geppetti P, Gandini S.

Melanoma Res. 2017 Jun;27(3):268-270. doi: 10.1097/CMR.0000000000000317.

PMID:
28346289
49.

Role of BMI and hormone therapy in melanoma risk: a case-control study.

De Giorgi V, Gori A, Savarese I, D'Errico A, Scarfì F, Papi F, Maio V, Covarelli P, Massi D, Gandini S.

J Cancer Res Clin Oncol. 2017 Jul;143(7):1191-1197. doi: 10.1007/s00432-017-2387-5. Epub 2017 Mar 13.

PMID:
28289899
50.

Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial.

Ruscica M, Pavanello C, Gandini S, Gomaraschi M, Vitali C, Macchi C, Morlotti B, Aiello G, Bosisio R, Calabresi L, Arnoldi A, Sirtori CR, Magni P.

Eur J Nutr. 2018 Mar;57(2):499-511. doi: 10.1007/s00394-016-1333-7. Epub 2016 Oct 18.

Supplemental Content

Loading ...
Support Center